awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33405241-15B8074E-49E2-4F55-AE5E-4B2FA00B0632
Q33405241-15B8074E-49E2-4F55-AE5E-4B2FA00B0632
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33405241-15B8074E-49E2-4F55-AE5E-4B2FA00B0632
Ruxolitinib: a new treatment option for myelofibrosis.
P2860
Q33405241-15B8074E-49E2-4F55-AE5E-4B2FA00B0632
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33405241-15B8074E-49E2-4F55-AE5E-4B2FA00B0632
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
de1b68ed23186f8f912e87b56912cd20e44acbc9
P2860
Lenalidomide plus prednisone results in durable clinical, histopathologic, and molecular responses in patients with myelofibrosis.